HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $235,000 | -68.7% | 410,189 | -29.5% | 0.04% | -56.6% |
| Q1 2022 | $751,000 | +19.2% | 582,137 | +5.2% | 0.10% | +5.3% |
| Q4 2021 | $630,000 | -25.6% | 553,273 | 0.0% | 0.09% | +56.7% |
| Q3 2021 | $847,000 | -68.7% | 553,273 | -59.5% | 0.06% | -72.6% |
| Q2 2021 | $2,703,000 | – | 1,365,059 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 57,309 | $178,000 | 0.03% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 15,552 | $48,000 | 0.00% |
| Squarepoint Ops LLC | 15,524 | $48,000 | 0.00% |
| ExodusPoint Capital Management, LP | 11,632 | $36,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33,215 | $103,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,786 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,233 | $91,000 | 0.00% |
| MORGAN STANLEY | 54 | $0 | 0.00% |